• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小分子 VCP/p97 ATPase 调节剂影响特定的 p97 细胞功能。

Small-Molecule Modulators of the ATPase VCP/p97 Affect Specific p97 Cellular Functions.

机构信息

Department of Cell Physiology and Metabolism , University of Geneva , 1211 Geneva 4 , Switzerland.

National Centre of Competence in Research (NCCR) in Chemical Biology , University of Geneva , Geneva , Switzerland.

出版信息

ACS Chem Biol. 2020 Jan 17;15(1):243-253. doi: 10.1021/acschembio.9b00832. Epub 2019 Dec 18.

DOI:10.1021/acschembio.9b00832
PMID:31790201
Abstract

VCP/p97 belongs to the AAA+ ATPase family and has an essential role in several cellular processes ranging from cell division to protein homeostasis. Compounds targeting p97 inhibit the main ATPase domain and cause cell death. Here, using PNA-encoded chemical libraries, we have identified two small molecules that target the regulatory domain of p97, comprising the N-terminal and the D1 ATPase domains, and do not cause cell death. One molecule, , inhibits the degradation of a p97-dependent reporter, whereas the other, , increases it. ATPase assays show that and do not affect the main catalytic domain of p97. Mapping of the binding site using a photoaffinity conjugate points to a cleft at the interface of the N-terminal and the D1 ATPase domains. We have therefore discovered two new compounds that bind to the regulatory domain of p97 and modulate specific p97 cellular functions. Using these compounds, we have revealed a role for p97 in the regulation of mitotic spindle orientation in HeLa cells.

摘要

VCP/p97 属于 AAA+ ATP 酶家族,在从细胞分裂到蛋白质动态平衡等多种细胞过程中发挥着重要作用。靶向 p97 的化合物会抑制其主要的 ATP 酶结构域并导致细胞死亡。在这里,我们使用 PNA 编码的化学文库,鉴定出两种靶向 p97 调节结构域的小分子,它们包含 N 端和 D1 ATP 酶结构域,并且不会导致细胞死亡。其中一种分子 ,抑制依赖于 p97 的报告蛋白的降解,而另一种分子 ,则增加其降解。ATP 酶实验表明, 和 不影响 p97 的主要催化结构域。使用光亲和标记物进行结合位点映射表明,它们结合在 N 端和 D1 ATP 酶结构域的界面缝隙处。因此,我们发现了两种新的可与 p97 调节结构域结合并调节特定 p97 细胞功能的化合物。利用这些化合物,我们揭示了 p97 在调控 HeLa 细胞有丝分裂纺锤体方向中的作用。

相似文献

1
Small-Molecule Modulators of the ATPase VCP/p97 Affect Specific p97 Cellular Functions.小分子 VCP/p97 ATPase 调节剂影响特定的 p97 细胞功能。
ACS Chem Biol. 2020 Jan 17;15(1):243-253. doi: 10.1021/acschembio.9b00832. Epub 2019 Dec 18.
2
Novel p97/VCP inhibitor induces endoplasmic reticulum stress and apoptosis in both bortezomib-sensitive and -resistant multiple myeloma cells.新型 p97/VCP 抑制剂诱导硼替佐米敏感和耐药多发性骨髓瘤细胞发生内质网应激和细胞凋亡。
Cancer Sci. 2019 Oct;110(10):3275-3287. doi: 10.1111/cas.14154. Epub 2019 Aug 14.
3
Specific inhibition of p97/VCP ATPase and kinetic analysis demonstrate interaction between D1 and D2 ATPase domains.对p97/VCP ATP酶的特异性抑制及动力学分析表明D1和D2 ATP酶结构域之间存在相互作用。
J Mol Biol. 2014 Jul 29;426(15):2886-99. doi: 10.1016/j.jmb.2014.05.022. Epub 2014 May 27.
4
p97 Composition Changes Caused by Allosteric Inhibition Are Suppressed by an On-Target Mechanism that Increases the Enzyme's ATPase Activity.p97 变构抑制引起的组成变化被一种增加酶的 ATP 酶活性的靶标机制所抑制。
Cell Chem Biol. 2016 Apr 21;23(4):517-28. doi: 10.1016/j.chembiol.2016.03.012.
5
A covalent p97/VCP ATPase inhibitor can overcome resistance to CB-5083 and NMS-873 in colorectal cancer cells.一种共价 p97/VCP ATP 酶抑制剂可以克服结直肠癌细胞对 CB-5083 和 NMS-873 的耐药性。
Eur J Med Chem. 2021 Mar 5;213:113148. doi: 10.1016/j.ejmech.2020.113148. Epub 2021 Jan 2.
6
ATP binding to p97/VCP D1 domain regulates selective recruitment of adaptors to its proximal N-domain.ATP 与 p97/VCP D1 结构域结合调节衔接蛋白对其近端 N 结构域的选择性募集。
PLoS One. 2012;7(12):e50490. doi: 10.1371/journal.pone.0050490. Epub 2012 Dec 3.
7
Structural and mechanistic insights into the arginine/lysine-rich peptide motifs that interact with P97/VCP.对与P97/VCP相互作用的富含精氨酸/赖氨酸的肽基序的结构和机制见解。
Biochim Biophys Acta. 2013 Dec;1834(12):2672-8. doi: 10.1016/j.bbapap.2013.09.021. Epub 2013 Oct 4.
8
Evaluating p97 inhibitor analogues for their domain selectivity and potency against the p97-p47 complex.评估p97抑制剂类似物对p97-p47复合物的结构域选择性和效力。
ChemMedChem. 2015 Jan;10(1):52-6. doi: 10.1002/cmdc.201402420. Epub 2014 Nov 6.
9
A Fragment-Based Ligand Screen Against Part of a Large Protein Machine: The ND1 Domains of the AAA+ ATPase p97/VCP.针对大型蛋白质机器一部分的基于片段的配体筛选:AAA+ ATP酶p97/VCP的ND1结构域
J Biomol Screen. 2015 Jul;20(6):788-800. doi: 10.1177/1087057115570550. Epub 2015 Feb 17.
10
Mutant p97 exhibits species-specific changes of its ATPase activity and compromises the UBXD9-mediated monomerisation of p97 hexamers.突变 p97 表现出其 ATP 酶活性的种属特异性变化,并损害 UBXD9 介导的 p97 六聚体单体化。
Eur J Cell Biol. 2016 Jun-Jul;95(6-7):195-207. doi: 10.1016/j.ejcb.2016.03.004. Epub 2016 Apr 7.

引用本文的文献

1
Structural insights into the coupling between VCP, an essential unfoldase, and a deubiquitinase.对必需解折叠酶VCP与去泛素化酶之间偶联的结构见解。
J Cell Biol. 2025 May 5;224(5). doi: 10.1083/jcb.202410148. Epub 2025 Mar 14.
2
Small Molecule Modulator of the mTORC2 Pathway Discovered from a DEL Library Designed to Bind to Pleckstrin Homology Domains.从旨在结合普列克底物蛋白同源结构域的DEL文库中发现的mTORC2信号通路小分子调节剂。
ACS Chem Biol. 2024 Dec 20;19(12):2502-2514. doi: 10.1021/acschembio.4c00597. Epub 2024 Nov 12.
3
Allosteric activation of VCP, an AAA unfoldase, by small molecule mimicry.
小分子模拟物对 VCP(一种 AAA 解旋酶)的别构激活。
Proc Natl Acad Sci U S A. 2024 Jun 11;121(24):e2316892121. doi: 10.1073/pnas.2316892121. Epub 2024 Jun 4.
4
VCP activator reverses nuclear proteostasis defects and enhances TDP-43 aggregate clearance in multisystem proteinopathy models.VCP 激活剂可逆转核蛋白稳态缺陷,并增强多系统蛋白病变模型中 TDP-43 聚集体的清除。
J Clin Invest. 2024 May 23;134(14):e169039. doi: 10.1172/JCI169039.
5
Discovery of novel benzylquinazoline molecules as p97/VCP inhibitors.新型苄基喹唑啉分子作为p97/VCP抑制剂的发现。
Front Pharmacol. 2023 Jun 14;14:1209060. doi: 10.3389/fphar.2023.1209060. eCollection 2023.
6
Molecular Mechanisms Driving and Regulating the AAA+ ATPase VCP/p97, an Important Therapeutic Target for Treating Cancer, Neurological and Infectious Diseases.驱动和调节 AAA+ ATPase VCP/p97 的分子机制,VCP/p97 是治疗癌症、神经和传染病的重要治疗靶点。
Biomolecules. 2023 Apr 24;13(5):737. doi: 10.3390/biom13050737.
7
Compounds activating VCP D1 ATPase enhance both autophagic and proteasomal neurotoxic protein clearance.化合物激活 VCP D1 ATPase 可增强自噬和蛋白酶体神经毒性蛋白清除。
Nat Commun. 2022 Jul 16;13(1):4146. doi: 10.1038/s41467-022-31905-0.
8
The Cure VCP Scientific Conference 2021: Molecular and clinical insights into neurodegeneration and myopathy linked to multisystem proteinopathy-1 (MSP-1).2021 年 Cure VCP 科学会议:与多系统蛋白病 1 (MSP-1)相关的神经退行性变和肌病的分子和临床见解。
Neurobiol Dis. 2022 Jul;169:105722. doi: 10.1016/j.nbd.2022.105722. Epub 2022 Apr 8.
9
A targeted covalent inhibitor of p97 with proteome-wide selectivity.一种具有全蛋白质组选择性的p97靶向共价抑制剂。
Acta Pharm Sin B. 2022 Feb;12(2):982-989. doi: 10.1016/j.apsb.2021.09.003. Epub 2021 Sep 8.
10
Strategies for developing DNA-encoded libraries beyond binding assays.超越结合测定的 DNA 编码文库的开发策略。
Nat Chem. 2022 Feb;14(2):129-140. doi: 10.1038/s41557-021-00877-x. Epub 2022 Feb 4.